{"id":3106,"date":"2023-07-06T17:32:11","date_gmt":"2023-07-06T23:32:11","guid":{"rendered":"https:\/\/udibi6748.live-website.com\/?page_id=3106"},"modified":"2024-01-11T08:23:53","modified_gmt":"2024-01-11T14:23:53","slug":"libraries","status":"publish","type":"page","link":"https:\/\/udibi.com.mx\/en\/libraries\/","title":{"rendered":"Libraries"},"content":{"rendered":"

[vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” align=”align_left” border_width=”2″ el_width=”10″ accent_color=”#a1bf3b” css=”.vc_custom_1635181647817{margin-top: 15px !important;margin-bottom: 1px !important;padding-bottom: 1px !important;}”][vc_custom_heading text=”Libraries” font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1688686323663{margin-top: 1px !important;padding-top: 15px !important;}”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” padding_top=”10″ padding_bottom=”10″][vc_column][vc_single_image image=”3162″ img_size=”full” alignment=”center”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” text_align=”center” padding_top=”10″ padding_bottom=”10″][vc_column width=”1\/2″][vc_column_text]<\/p>\n

Our platforms, called ALTHEA (from the Greek ‘healing’), consist of a family of semi-synthetic human antibody fragment phage display libraries.<\/span><\/p>\n

The first version, ALTHEA Gold Libraries\u2122, was developed in Mexico through a collaborative effort between GlobalBio Inc. and UDIBI in 2018.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/2″][vc_single_image image=”3490″ img_size=”medium” alignment=”center”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” text_align=”center” padding_top=”10″ padding_bottom=”10″][vc_column width=”1\/4″][vc_column_text]<\/p>\n

From our initial design, we generated a family of 5 ALTHEA libraries built with various genes and antibody fragment formats.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”3\/4″][vc_single_image image=”3496″ img_size=”full” alignment=”center”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” text_align=”center” padding_top=”10″ padding_bottom=”10″][vc_column width=”1\/3″][vc_row_inner][vc_column_inner width=”1\/4″][vc_icon icon_fontawesome=”fas fa-check-circle” color=”custom” size=”lg” align=”center” custom_color=”#96e4ec”][\/vc_column_inner][vc_column_inner width=”3\/4″][vc_custom_heading text=”High specificity” font_container=”tag:h2|font_size:25|text_align:center|color:%2334567c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″][vc_row_inner][vc_column_inner width=”1\/4″][vc_icon icon_fontawesome=”fas fa-check-circle” color=”custom” size=”lg” align=”center” custom_color=”#96e4ec”][\/vc_column_inner][vc_column_inner width=”3\/4″][vc_custom_heading text=”Affinity in the
\nsub-nanomolar range” font_container=”tag:h2|font_size:25|text_align:center|color:%2334567c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″][vc_row_inner][vc_column_inner width=”1\/4″][vc_icon icon_fontawesome=”fas fa-check-circle” color=”custom” size=”lg” align=”center” custom_color=”#96e4ec”][\/vc_column_inner][vc_column_inner width=”3\/4″][vc_custom_heading text=”Pharmaceutical
\ndevelopment” font_container=”tag:h2|font_size:25|text_align:center|color:%2334567c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” text_align=”center” padding_top=”10″ padding_bottom=”10″][vc_column width=”2\/3″][vc_single_image image=”3510″ img_size=”full” alignment=”center”][\/vc_column][vc_column width=”1\/3″][vc_column_text]<\/p>\n

ALTHEA Libraries\u2122 was built using a unique three-step process:
\nprimary synthesis, thermal selection, and addition of natural diversity.
\n<\/span><\/p>\n

This process was specifically designed to increase the diversity and functionality of our libraries.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” padding_top=”10″ padding_bottom=”10″][vc_column][vc_single_image image=”3971″ img_size=”full” alignment=”center”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” padding_top=”10″ padding_bottom=”10″][vc_column width=”1\/2″][vc_single_image image=”3513″ img_size=”full” alignment=”center”][\/vc_column][vc_column width=”1\/2″][vc_column_text]<\/p>\n

The ALTHEA Libraries \u2122 family has allowed us to develop a portfolio of innovative Mexican antibodies and provide discovery services to various companies in Mexico and the United States.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” padding_top=”10″ padding_bottom=”10″][vc_column width=”2\/3″][vc_custom_heading text=”We can generate antibodies against any target!” font_container=”tag:h2|font_size:25|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1690067978737{margin-top: 1px !important;padding-top: 15px !important;}”][vc_column_text]<\/p>\n

The innovative antibodies generated using ALTHEA libraries \u2122M are highly specific, capable of recognizing their antigen at subnanomolar concentrations, and stable, ensuring their functionality in various applications.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/3″][vc_single_image image=”3516″ img_size=”full” alignment=”center”][\/vc_column][\/vc_row][vc_row equal_height=”yes” content_placement=”middle” padding_top=”10″ padding_bottom=”10″][vc_column]